What is Savara Inc?
, a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.02B.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.